Evercore ISI Group Downgrades Inspire Medical Systems to In-Line, Lowers Price Target to $40

Benzinga Newsdesk www.benzinga.com Negative 90.7%

Neg 90.7% Neu 0% Pos 0%

Evercore ISI Group analyst Daniel Markowitz downgrades Inspire Medical Systems (NYSE:INSP) from Outperform to In-Line and lowers the price target from $55 to $40.